Acrivon Therapeutics, Inc.(NASDAQ:ACRV) 
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to specific medicine by utilizing its proteomics-based patient responder identification platform, Acrivon ...
Website: https://www.acrivon.com
Founded: 2018
Full Time Employees: 35
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.59
H 1.68
L 1.40
C 1.51
V 317,550
10EMA 1.51
20EMA 1.51
60EMA 1.51
120EMA 1.51
250EMA 1.51